ABIOMED, inc (ABMD) Q2 2022 Earnings Call Transcript

·50-min read
ABIOMED, inc (ABMD) Q2 2022 Earnings Call Transcript

With that, let me turn the call over to Abiomed's Chairman, President and Chief Executive Officer, Mike Minogue. During the second quarter, we made progress on advancing our innovation, expanding clinical evidence and leveraging our premier commercial field team in a challenging environment with COVID and hospital staffing shortages.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting